Suchergebnisse - "Masui, Sho"

PubPharm (18)

1

Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria : a case series

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Masuda, T. | Funakoshi, T. | Horimatsu, T. | +9

2

Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort

enthalten in: Modern rheumatology | 2024

von Kawakami, T. | Masui, S. | Onishi, A. | +11

3

Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan : Results of a Nationwide Survey

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Miyamoto, T. | Izawa, K. | Masui, S. | +99

4

Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis

enthalten in: Biological & pharmaceutical bulletin | 2023

von Masui, S. | Yonezawa, A. | Nakamura, M. | +20

5

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

enthalten in: Pharmaceutical research | 2022

von Masui, S. | Yonezawa, A. | Yokoyama, K. | +18

6

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

enthalten in: Pharmaceutical research | 2022

von Masui, S. | Yonezawa, A. | Yokoyama, K. | +18

7

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

enthalten in: Pharmaceutical research | 2022

von Masui, S. | Yonezawa, A. | Yokoyama, K. | +18

8

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

enthalten in: Pharmaceutical research | 2022

von Masui, S. | Yonezawa, A. | Yokoyama, K. | +18

9

Infliximab Treatment Persistence among Japanese Patients with Chronic Inflammatory Diseases : A Retrospective Japanese Claims Data Study

enthalten in: Biological & pharmaceutical bulletin | 2022

von Masui, S. | Yonezawa, A. | Momo, K. | +5

10

Potential Application of Measuring Serum Infliximab Levels in Rheumatoid Arthritis Management: A Retrospective Study based on KURAMA Cohort Data

enthalten in: ResearchSquare.com | 2021

von Nakae, K. | Masui, S. | Yonezawa, A. | +18